Nuclear expression of 14-3-3 sigma is related to prognosis in patients with esophageal squamous cell carcinoma.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Anticancer Research

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 21187508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic significance of 14-3-3sigma expression in oral squamous cell carcinoma (OSCC).

  2009cited by this paper
• The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas

  2008cited by this paper
• 14-3-3sigma negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma.

  2007cited by this paper
• Expression of p53R2 Is Related to Prognosis in Patients with Esophageal Squamous Cell Carcinoma

  2006cited by this paper
• Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients

  2006cited by this paper
• Epigenetic silencing of 14-3-3sigma in cancer.

  2006cited by this paper
• 000255 DNA METHYLATION IN CLEAR CELL OVARIAN CARCINOMA

  2005cited by this paper
• 14-3-3sigma in endometrial cancer--a possible prognostic marker in early-stage cancer.

  2005cited by this paper
• Isoform‐specific expression of 14‐3‐3 proteins in human lung cancer tissues

  2005cited by this paper
• Immunohistochemical expression of 14‐3‐3 sigma protein in human urological and gynecological tumors using a multi‐tumor microarray analysis

  2005cited by this paper
• 14-3-3σ Expression Is an Independent Prognostic Parameter for Poor Survival in Colorectal Carcinoma Patients

  2005cited by this paper
• 14-3-3 proteins—an update

  2005cited by this paper
• Distribution and significance of 14‐3‐3σ, a novel myoepithelial marker, in normal, benign, and malignant breast tissue

  2004cited by this paper
• Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.

  2004cited by this paper
• Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation.

  2004cited by this paper
• The clinical implication of 14-3-3 sigma expression in primary gastrointestinal malignancy.

  2004cited by this paper
• 14-3-3 proteins: structure, function, and regulation.

  2000cited by this paper
• 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage.

  1999cited by this paper
• 14-3-3σ is required to prevent mitotic catastrophe after DNA damage

  1999cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• The structural basis for 14-3-3:phosphopeptide binding specificity.

  1997cited by this paper
• 14-3-3sigma is a p53-regulated inhibitor of G2/M progression.

  1997cited by this paper

• Role and clinical significance of the DNA methylation of 14-3-3σ in cancer (Review)

  2025cites this paper
• Stratifin (SFN) Regulates Cervical Cancer Cell Proliferation, Apoptosis, and Cytoskeletal Remodeling and Metastasis Progression Through LIMK2/Cofilin Signaling

  2023cites this paper
• A Computational Approach to Justifying Stratifin as a Candidate Diagnostic and Prognostic Biomarker for Pancreatic Cancer

  2022cites this paper
• Association between TP53 gene deletion and protein expression in esophageal squamous cell carcinoma and its prognostic significance

  2020cites this paper
• H19/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells.

  2019cites this paper
• MiR-597 Targeting 14-3-3σ Enhances Cellular Invasion and EMT in Nasopharyngeal Carcinoma Cells.

  2019cites this paper
• Molecular carcinogenesis in equine penile cancer: A potential animal model for human penile cancer.

  2018influential citation
• Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma

  2018cites this paper
• The Mitochondrial Genes BAK1, FIS1 and SFN are Linked with Alterations in Mitochondrial Membrane Potential in Barrett’s Esophagus

  2018cites this paper
• YY1 and KLF4: Their Role in Gastrointestinal Malignancies

  2017cites this paper
• Investigation into mitochondrial function and energy metabolism and their connectivity with protumourigenic cellular proceses in Barrett's oesophagus

  2016cites this paper
• 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules

  2016cites this paper
• Loss of the 14-3-3σ is essential for LASP1-mediated colorectal cancer progression via activating PI3K/AKT signaling pathway

  2016cites this paper
• Expression of cell cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder.

  2015cites this paper
• Epigenetics Territory and Cancer

  2015cites this paper
• Epigenetics and Three Main Clinical Aspects of Breast Cancer Management

  2015cites this paper
• Downregulation of 14-3-3σ Correlates with Multistage Carcinogenesis and Poor Prognosis of Esophageal Squamous Cell Carcinoma

  2014influential citation
• Erratum to: - Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer

  2014cites this paper
• p53 is an independent prognostic factor in operable esophageal squamous cell carcinoma: a large-scale study with a long follow-up

  2014cites this paper
• Molecular mechanisms of acquired gemcitabine resistance in pancreatic cancer

  2014cites this paper
• p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma

  2013cites this paper
• Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer

  2013cites this paper
• DNA methylation-based biomarkers in serum of patients with breast cancer.

  2012cites this paper
• Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma.

  2011cites this paper